RSS
Opicapone
Licence agreement formed for Parkinson’s treatment to be made available in China
An exclusive licence agreement has been announced for the importation, packaging and commercialisation of Opicapone — a new treatment for Parkinson’s disease — in China (excluding Hong Kong, Macao and Taiwan). Read more
